Cargando…
Evaluation of antiglaucoma drug treatment awareness and patient-reported medication adherence: Determinants of glaucoma management
INTRODUCTION: Primary open angle glaucoma (POAG) treatment is characterized by long-duration therapy, prescription variability, and non-adherence. Patient awareness toward drug treatment is crucial to ensure adherence. The present study was planned to evaluate drug treatment awareness, patient-perce...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer - Medknow
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10394530/ https://www.ncbi.nlm.nih.gov/pubmed/37313943 http://dx.doi.org/10.4103/jpgm.jpgm_905_22 |
_version_ | 1785083391355387904 |
---|---|
author | Tripathi, RK Shah, A Jalgaonkar, SV Kerkar, S |
author_facet | Tripathi, RK Shah, A Jalgaonkar, SV Kerkar, S |
author_sort | Tripathi, RK |
collection | PubMed |
description | INTRODUCTION: Primary open angle glaucoma (POAG) treatment is characterized by long-duration therapy, prescription variability, and non-adherence. Patient awareness toward drug treatment is crucial to ensure adherence. The present study was planned to evaluate drug treatment awareness, patient-perceived drug adherence, and prescription patterns in POAG patients. METHODOLOGY: This was a cross-sectional, single-center, questionnaire-based study conducted in the ophthalmology out patient department of a tertiary care hospital from April 2020 to November 2021. Patients of either gender, aged 40–70 years, with a confirmed diagnosis of POAG, who had records of POAG medications for at least last 3 months and who provided written informed consent, were included. Prescription details were recorded, and subsequently, patients were administered a pre-validated drug treatment awareness (14 items) questionnaire, a self-reported medication adherence (9-item) questionnaire, and then they performed eye drop instillation in a simulated setting. RESULTS: The total number of patients enrolled was 180, which yielded 200 prescriptions. The mean drug treatment awareness score was 8.18 ± 3.30, and 135 (75%) patients scored more than 50% (≥7/14). Similarly, 159 patients (83.33%) had scored >50% (i.e. >5/9), with a mean score of 6.30 ± 1.70 in the medication treatment adherence questionnaire. The mean eye drop instillation performance score was 7.18 ± 1.20. The 200 POAG prescriptions containing 306 drugs were analyzed, with beta blockers (184/200, 92%) and timolol (168/200, 84% encounters) being the highest prescribed classes/drugs. CONCLUSION: POAG patients did have adequate treatment awareness with good self-reported medication adherence and performance of eye drop instillation technique. Around 25% patients lacked awareness; hence, reinforcement education programs on medication regimens need to be implemented. |
format | Online Article Text |
id | pubmed-10394530 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | Wolters Kluwer - Medknow |
record_format | MEDLINE/PubMed |
spelling | pubmed-103945302023-08-03 Evaluation of antiglaucoma drug treatment awareness and patient-reported medication adherence: Determinants of glaucoma management Tripathi, RK Shah, A Jalgaonkar, SV Kerkar, S J Postgrad Med Original Article INTRODUCTION: Primary open angle glaucoma (POAG) treatment is characterized by long-duration therapy, prescription variability, and non-adherence. Patient awareness toward drug treatment is crucial to ensure adherence. The present study was planned to evaluate drug treatment awareness, patient-perceived drug adherence, and prescription patterns in POAG patients. METHODOLOGY: This was a cross-sectional, single-center, questionnaire-based study conducted in the ophthalmology out patient department of a tertiary care hospital from April 2020 to November 2021. Patients of either gender, aged 40–70 years, with a confirmed diagnosis of POAG, who had records of POAG medications for at least last 3 months and who provided written informed consent, were included. Prescription details were recorded, and subsequently, patients were administered a pre-validated drug treatment awareness (14 items) questionnaire, a self-reported medication adherence (9-item) questionnaire, and then they performed eye drop instillation in a simulated setting. RESULTS: The total number of patients enrolled was 180, which yielded 200 prescriptions. The mean drug treatment awareness score was 8.18 ± 3.30, and 135 (75%) patients scored more than 50% (≥7/14). Similarly, 159 patients (83.33%) had scored >50% (i.e. >5/9), with a mean score of 6.30 ± 1.70 in the medication treatment adherence questionnaire. The mean eye drop instillation performance score was 7.18 ± 1.20. The 200 POAG prescriptions containing 306 drugs were analyzed, with beta blockers (184/200, 92%) and timolol (168/200, 84% encounters) being the highest prescribed classes/drugs. CONCLUSION: POAG patients did have adequate treatment awareness with good self-reported medication adherence and performance of eye drop instillation technique. Around 25% patients lacked awareness; hence, reinforcement education programs on medication regimens need to be implemented. Wolters Kluwer - Medknow 2023 2023-06-13 /pmc/articles/PMC10394530/ /pubmed/37313943 http://dx.doi.org/10.4103/jpgm.jpgm_905_22 Text en Copyright: © 2023 Journal of Postgraduate Medicine https://creativecommons.org/licenses/by-nc-sa/4.0/This is an open access journal, and articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as appropriate credit is given and the new creations are licensed under the identical terms. |
spellingShingle | Original Article Tripathi, RK Shah, A Jalgaonkar, SV Kerkar, S Evaluation of antiglaucoma drug treatment awareness and patient-reported medication adherence: Determinants of glaucoma management |
title | Evaluation of antiglaucoma drug treatment awareness and patient-reported medication adherence: Determinants of glaucoma management |
title_full | Evaluation of antiglaucoma drug treatment awareness and patient-reported medication adherence: Determinants of glaucoma management |
title_fullStr | Evaluation of antiglaucoma drug treatment awareness and patient-reported medication adherence: Determinants of glaucoma management |
title_full_unstemmed | Evaluation of antiglaucoma drug treatment awareness and patient-reported medication adherence: Determinants of glaucoma management |
title_short | Evaluation of antiglaucoma drug treatment awareness and patient-reported medication adherence: Determinants of glaucoma management |
title_sort | evaluation of antiglaucoma drug treatment awareness and patient-reported medication adherence: determinants of glaucoma management |
topic | Original Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10394530/ https://www.ncbi.nlm.nih.gov/pubmed/37313943 http://dx.doi.org/10.4103/jpgm.jpgm_905_22 |
work_keys_str_mv | AT tripathirk evaluationofantiglaucomadrugtreatmentawarenessandpatientreportedmedicationadherencedeterminantsofglaucomamanagement AT shaha evaluationofantiglaucomadrugtreatmentawarenessandpatientreportedmedicationadherencedeterminantsofglaucomamanagement AT jalgaonkarsv evaluationofantiglaucomadrugtreatmentawarenessandpatientreportedmedicationadherencedeterminantsofglaucomamanagement AT kerkars evaluationofantiglaucomadrugtreatmentawarenessandpatientreportedmedicationadherencedeterminantsofglaucomamanagement |